Trial Profile
Phase I gastrointestinal motility trial of orally administered benzhydrocodone/paracetamol (KP 201), compared with hydrocodone/paracetamol.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2023
Price :
$35
*
At a glance
- Drugs Benzhydrocodone/paracetamol (Primary) ; Hydrocodone/paracetamol
- Indications Pain
- Focus Adverse reactions
- Sponsors Zevra Therapeutics
- 22 Feb 2023 According to a KemPharm media release, KemPharm has changed its name to Zevra Therapeutics.
- 17 Sep 2014 New trial record